Synapse - Surgery

Results (19)

Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease

Research Letter

Goyal, G.; Reiner, A. S.; Bossert, D.; Sigler, A. M.; Lacouture, M. E.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; Diamond, E. L.
Blood (2025)

Fulltext@MSK | Save

Histiocytosis of the orbit and its association with KRAS mutations

Research Letter

Francis, J. H.; Silverman, R. F.; Canestraro, J.; Bossert, D.; Della Rocca, D.; Hatzoglou, V.; Abramson, D. H.; Diamond, E. L.
Blood Advances (2024)

Fulltext@MSK | Save

Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society

Meeting Abstract

Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
Blood (2023)

Fulltext@MSK | Save

Long-term outcomes with single-agent BRAF-inhibitor therapy in Erdheim-Chester disease

Meeting Abstract

Goyal, G.; Reiner, A.; Bossert, D.; Sigler, A.; Buthorn, J.; Lacouture, M.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; more...
Blood (2023)

Fulltext@MSK | Save

Phase Ib/II trial of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab and lenalidomide in refractory/recurrent primary (PCNSL) and secondary central nervous system lymphoma (SCNSL)

Meeting Abstract

Grommes, C.; Piotrowski, A.; Pentsova, E.; Gavrilovic, I.; Stone, J. B.; Lin, A.; Wongchai, V.; Madzsar, J. T.; Malani, R.; Nolan, C.; more...
Blood (2022)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence

Meeting Abstract

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
Blood (2021)

Fulltext@MSK | Save

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Journal Article

Dunbar, A.; Bolton, K. L.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J.; Kelly, D.; Farina, M.; Cordner, K. B.; more...
Blood (2021)

Fulltext@MSK | Save

Phase Ib trial with dose expansion of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab and lenalidomide in patients with refractory/recurrent primary central nervous system lymphoma (PCNSL) and refractory/recurrent secondary central nervous system lymphoma (SCNSL)

Meeting Abstract

Grommes, C.; Piotrowski, A.; Pentsova, E.; Nolan, C.; Francis, J.; DeAngelis, L.; Schaff, L.; Mellinghoff, I. K.
Blood (2020)

Fulltext@MSK | Save

Clinical characteristics and follow-up post-surgery of women with BIA-ALCL operated at a single institution

Meeting Abstract

Ghione, P.; Vorstenbosch, J.; Cordeiro, P. G.; Arcila, M. E.; Moskowitz, A. J.; Owens, C.; Galasso, N.; Nelson, J. A.; Dogan, A.; McCarthy, C. M.; more...
Blood (2020)

Fulltext@MSK | Save

Incidence of delayed seromas and related risk of BIA-ALCL in a cohort of 3521 breast cancer women with textured implants prospectively followed long term

Meeting Abstract

Ghione, P.; Cordeiro, P.; Seshan, V.; Galasso, N.; Ganesan, N.; Hu, Q.; Dogan, A.; Horwitz, S. M.
Blood (2019)

Fulltext@MSK | Save